EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

Conditions: Heart Failure With Preserved Ejection Fraction; End Stage Renal Disease on Dialysis Interventions: Drug: Empagliflozin 25 MG; Drug: Placebo Sponsors: National Taiwan University Hospital; Shin Kong Wu Ho-Su Memorial Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials